These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 18336925

  • 21. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M, Suzutani T, Mizuta K, Kurane I, Morikawa S.
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [Abstract] [Full Text] [Related]

  • 22. Resistance testing of clinical varicella-zoster virus strains.
    Sauerbrei A, Taut J, Zell R, Wutzler P.
    Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D.
    Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
    [Abstract] [Full Text] [Related]

  • 25. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [Abstract] [Full Text] [Related]

  • 26. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE.
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [Abstract] [Full Text] [Related]

  • 27. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, O'Leary Bartus J, Van Horn MM, Sathe GM, Van Horn S, Kelly MD, Bacon TH, Leary JJ.
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [Abstract] [Full Text] [Related]

  • 28. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K.
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [Abstract] [Full Text] [Related]

  • 29. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
    Duan R, de Vries RD, van Dun JM, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM.
    J Infect Dis; 2009 Nov 01; 200(9):1402-14. PubMed ID: 19795980
    [Abstract] [Full Text] [Related]

  • 30. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
    Bestman-Smith J, Schmit I, Papadopoulou B, Boivin G.
    J Virol; 2001 Apr 01; 75(7):3105-10. PubMed ID: 11238837
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.
    Sarisky RT, Cano R, Nguyen TT, Wittrock RJ, Duffy KE, Clark P, Bartus JO, Bacon TH, Caspers-Velu L, Hodinka RL, Leary JJ.
    Clin Infect Dis; 2001 Dec 15; 33(12):2034-9. PubMed ID: 11712095
    [Abstract] [Full Text] [Related]

  • 34. Long-term observation of herpes simplex virus type 1 (HSV-1) infection in a child with Wiskott-Aldrich syndrome and a possible reactivation mechanism for thymidine kinase-negative HSV-1 in humans.
    Shiota T, Kurane I, Morikawa S, Saijo M.
    Jpn J Infect Dis; 2011 Dec 15; 64(2):121-6. PubMed ID: 21519125
    [Abstract] [Full Text] [Related]

  • 35. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Burrel S, Deback C, Agut H, Boutolleau D.
    Antimicrob Agents Chemother; 2010 Nov 15; 54(11):4833-42. PubMed ID: 20733037
    [Abstract] [Full Text] [Related]

  • 36. Herpes simplex virus resistance to antiviral drugs.
    Morfin F, Thouvenot D.
    J Clin Virol; 2003 Jan 15; 26(1):29-37. PubMed ID: 12589832
    [Abstract] [Full Text] [Related]

  • 37. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A, Boivin G.
    J Clin Virol; 2006 Sep 15; 37(1):34-7. PubMed ID: 16781887
    [Abstract] [Full Text] [Related]

  • 38. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.
    Frobert E, Burrel S, Ducastelle-Lepretre S, Billaud G, Ader F, Casalegno JS, Nave V, Boutolleau D, Michallet M, Lina B, Morfin F.
    Antiviral Res; 2014 Nov 15; 111():36-41. PubMed ID: 25218782
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M, Okuda T, Shiraki K.
    Antiviral Res; 2006 Nov 15; 72(2):157-61. PubMed ID: 16797734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.